Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Klaviyo Inc a un objectif de cours consensus de $42.52, basé sur les évaluations des 26 analystes. Le plus élevé est de $60 attribué par Loop Capital le décembre 23, 2024, et le plus bas est de $31 attribué par Scotiabank le avril 24, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Citigroup, TD Cowen et Piper Sandler le août 7, 2025, août 6, 2025 et août 6, 2025. Avec un objectif de cours moyen de $50.33 entre Citigroup, TD Cowen et Piper Sandler, il y a une variation implicite de 57.14% upside pour Klaviyo Inc à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/07/2025 | 56.1% | Citigroup | $40 → $50 | Upgrade | Neutral → Buy | |||
08/06/2025 | 43.62% | TD Cowen | $45 → $46 | Maintains | Buy | |||
08/06/2025 | 71.71% | Piper Sandler | $40 → $55 | Maintains | Overweight | |||
08/06/2025 | 43.62% | Benchmark | $44 → $46 | Maintains | Buy | |||
08/06/2025 | 15.52% | Macquarie | $37 → $37 | Maintains | Neutral | |||
07/15/2025 | 24.88% | Stifel | $45 → $40 | Maintains | Buy | |||
06/13/2025 | 24.88% | Wells Fargo | $32 → $40 | Upgrade | Equal-Weight → Overweight | |||
06/03/2025 | 49.86% | Cantor Fitzgerald | → $48 | Assumes | → Overweight | |||
05/07/2025 | 37.37% | Goldman Sachs | $51 → $44 | Maintains | Buy | |||
05/07/2025 | 37.37% | Benchmark | $43 → $44 | Maintains | Buy | |||
05/07/2025 | 18.64% | Barclays | $35 → $38 | Maintains | Overweight | |||
05/07/2025 | 40.49% | Needham | $56 → $45 | Maintains | Buy | |||
05/07/2025 | 24.88% | Piper Sandler | $35 → $40 | Maintains | Overweight | |||
05/05/2025 | -0.09% | Wells Fargo | $26 → $32 | Maintains | Equal-Weight | |||
04/24/2025 | -3.22% | Scotiabank | $45 → $31 | Maintains | Sector Perform | |||
04/23/2025 | 9.27% | Piper Sandler | $53 → $35 | Maintains | Overweight | |||
04/23/2025 | 15.52% | Baird | $54 → $37 | Maintains | Outperform | |||
04/22/2025 | -18.83% | Wells Fargo | $45 → $26 | Maintains | Equal-Weight | |||
04/21/2025 | 9.27% | Barclays | $51 → $35 | Maintains | Overweight | |||
04/16/2025 | 6.15% | Morgan Stanley | $50 → $34 | Maintains | Equal-Weight | |||
04/16/2025 | 24.88% | Truist Securities | $55 → $40 | Maintains | Buy | |||
04/15/2025 | 24.88% | Mizuho | $52 → $40 | Maintains | Outperform | |||
03/21/2025 | 34.25% | Stephens & Co. | → $43 | Initiates | → Overweight | |||
03/19/2025 | 34.25% | Stephens & Co. | → $43 | Initiates | → Overweight | |||
02/21/2025 | 74.84% | Needham | $56 → $56 | Reiterates | Buy → Buy | |||
02/21/2025 | 65.47% | Piper Sandler | $53 → $53 | Reiterates | Overweight → Overweight | |||
02/20/2025 | 68.59% | Stifel | $45 → $54 | Maintains | Buy | |||
02/20/2025 | 59.23% | Barclays | $47 → $51 | Maintains | Overweight | |||
02/20/2025 | 59.23% | Goldman Sachs | $45 → $51 | Maintains | Buy | |||
02/20/2025 | 62.35% | Mizuho | $42 → $52 | Maintains | Outperform | |||
02/20/2025 | 56.1% | Canaccord Genuity | $40 → $50 | Maintains | Buy | |||
02/20/2025 | 56.1% | Morgan Stanley | $47 → $50 | Maintains | Equal-Weight | |||
02/20/2025 | 68.59% | Cantor Fitzgerald | $47 → $54 | Maintains | Overweight | |||
02/20/2025 | 68.59% | Baird | $52 → $54 | Maintains | Outperform | |||
02/20/2025 | 68.59% | Benchmark | $51 → $54 | Maintains | Buy | |||
02/20/2025 | 40.49% | Wells Fargo | $48 → $45 | Maintains | Equal-Weight | |||
02/20/2025 | 65.47% | Piper Sandler | $50 → $53 | Maintains | Overweight | |||
02/20/2025 | 74.84% | Needham | $46 → $56 | Maintains | Buy | |||
02/19/2025 | 59.23% | Benchmark | $40 → $51 | Maintains | Buy | |||
02/12/2025 | 49.86% | Wells Fargo | $41 → $48 | Maintains | Equal-Weight | |||
02/11/2025 | 49.86% | Citigroup | $39 → $48 | Maintains | Neutral | |||
01/29/2025 | 40.49% | Scotiabank | $35 → $45 | Maintains | Sector Perform | |||
01/13/2025 | 46.74% | Morgan Stanley | $38 → $47 | Maintains | Equal-Weight | |||
01/07/2025 | 28% | Wells Fargo | $37 → $41 | Maintains | Equal-Weight | |||
01/06/2025 | 56.1% | Piper Sandler | $45 → $50 | Maintains | Overweight | |||
12/23/2024 | 87.32% | Loop Capital | $45 → $60 | Maintains | Buy | |||
12/13/2024 | 40.49% | Keybanc | $42 → $45 | Maintains | Overweight | |||
12/06/2024 | 46.74% | Barclays | $43 → $47 | Maintains | Overweight | |||
11/08/2024 | 12.39% | Macquarie | $36 → $36 | Maintains | Neutral | |||
11/07/2024 | 34.25% | Barclays | $41 → $43 | Maintains | Overweight | |||
11/07/2024 | 31.13% | Mizuho | $37 → $42 | Maintains | Outperform | |||
11/07/2024 | 43.62% | Needham | $40 → $46 | Maintains | Buy | |||
11/07/2024 | 24.88% | Canaccord Genuity | $32 → $40 | Maintains | Buy | |||
11/07/2024 | 40.49% | Baird | $42 → $45 | Maintains | Outperform | |||
11/07/2024 | 46.74% | Cantor Fitzgerald | $33 → $47 | Maintains | Overweight | |||
11/07/2024 | 24.88% | Benchmark | $42 → $40 | Maintains | Buy | |||
10/31/2024 | 12.39% | Macquarie | — | → $36 | Initiates | → Neutral | ||
10/24/2024 | 31.13% | Benchmark | $42 → $42 | Reiterates | Buy → Buy | |||
10/22/2024 | 40.49% | Stifel | → $45 | Initiates | → Buy | |||
10/18/2024 | 40.49% | Piper Sandler | $34 → $45 | Maintains | Overweight | |||
10/16/2024 | 15.52% | Wells Fargo | → $37 | Initiates | → Equal-Weight | |||
10/11/2024 | 28% | Barclays | $32 → $41 | Maintains | Overweight | |||
10/10/2024 | 31.13% | Baird | $35 → $42 | Maintains | Outperform | |||
09/30/2024 | 31.13% | Benchmark | → $42 | Initiates | → Buy | |||
09/04/2024 | 24.88% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
08/08/2024 | 15.52% | Mizuho | $35 → $37 | Maintains | Outperform | |||
08/08/2024 | -0.09% | Barclays | $29 → $32 | Maintains | Overweight | |||
08/08/2024 | 3.03% | Keybanc | → $33 | Upgrade | Sector Weight → Overweight | |||
08/08/2024 | 3.03% | Cantor Fitzgerald | $31 → $33 | Maintains | Overweight | |||
08/08/2024 | 6.15% | Piper Sandler | $30 → $34 | Maintains | Overweight | |||
07/12/2024 | -6.34% | Piper Sandler | $38 → $30 | Maintains | Overweight | |||
06/12/2024 | -9.46% | Barclays | $25 → $29 | Upgrade | Equal-Weight → Overweight | |||
05/17/2024 | 24.88% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
05/09/2024 | -3.22% | Cantor Fitzgerald | $31 → $31 | Reiterates | Overweight → Overweight | |||
05/09/2024 | 24.88% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
05/09/2024 | -0.09% | Canaccord Genuity | $37 → $32 | Maintains | Buy | |||
05/09/2024 | -21.95% | Barclays | $32 → $25 | Maintains | Equal-Weight | |||
05/09/2024 | 9.27% | Mizuho | $40 → $35 | Maintains | Buy | |||
05/09/2024 | 9.27% | Baird | $40 → $35 | Maintains | Outperform | |||
04/17/2024 | -0.09% | Morgan Stanley | $37 → $32 | Maintains | Equal-Weight | |||
04/16/2024 | -3.22% | Cantor Fitzgerald | → $31 | Initiates | → Overweight | |||
04/02/2024 | -6.34% | Scotiabank | → $30 | Initiates | → Sector Perform | |||
03/21/2024 | — | Keybanc | — | Initiates | → Sector Weight | |||
03/20/2024 | 9.27% | FBN Securities | → $35 | Initiates | → Outperform | |||
03/01/2024 | 24.88% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
02/28/2024 | 24.88% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
02/28/2024 | 15.52% | Morgan Stanley | $38 → $37 | Maintains | Equal-Weight | |||
02/28/2024 | 18.64% | Piper Sandler | → $38 | Reiterates | Overweight → Overweight | |||
02/05/2024 | 12.39% | Goldman Sachs | → $36 | Upgrade | Neutral → Buy | |||
01/24/2024 | 18.64% | Piper Sandler | → $38 | Reiterates | Overweight → Overweight | |||
01/12/2024 | -0.09% | Barclays | $37 → $32 | Maintains | Equal-Weight | |||
12/19/2023 | 24.88% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
12/08/2023 | 24.88% | Loop Capital | → $40 | Initiates | → Buy | |||
11/08/2023 | 18.64% | Piper Sandler | → $38 | Reiterates | Overweight → Overweight | |||
10/16/2023 | 18.64% | Citigroup | → $38 | Initiates | → Neutral | |||
10/16/2023 | 15.52% | Canaccord Genuity | → $37 | Initiates | → Buy | |||
10/16/2023 | 24.88% | Mizuho | → $40 | Initiates | → Buy | |||
10/16/2023 | 31.13% | TD Cowen | → $42 | Initiates | → Outperform | |||
10/16/2023 | — | William Blair | — | Initiates | → Outperform | |||
10/16/2023 | 15.52% | Barclays | → $37 | Initiates | → Equal-Weight |
Le dernier objectif de prix pour Klaviyo (NYSE:KVYO) a été rapporté par Citigroup le août 7, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $50.00 s'attendant à ce que KVYO se rise dans les 12 prochains mois (un possible changement de 55.86% upside). 65 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Klaviyo (NYSE:KVYO) a été fournie par Citigroup, et Klaviyo amélioré leur note buy.
La dernière amélioration pour Klaviyo Inc a eu lieu le août 7, 2025 lorsque Citigroup a augmenté leur objectif de prix à $50. Citigroup avait précédemment a neutral pour Klaviyo Inc.
Il n'y a pas de dernière réduction pour Klaviyo.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Klaviyo, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Klaviyo a été déposée le août 7, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 7, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Klaviyo (KVYO) était un amélioré avec un objectif de prix de $40.00 à $50.00. Le prix actuel de Klaviyo (KVYO) est de $32.08, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.